レボチロキシンの世界市場2020:メーカー別、地域別、種類・用途別

【英語タイトル】Global Levothyroxine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20OC15418)・商品コード:GIR20OC15418
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年10月
・ページ数:101
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥793,440見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本書では、レボチロキシンの世界市場を調査対象にし、レボチロキシンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(固体スライス、注射用ボトル)、用途別分析(病院、化学者店、その他医療機関)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。
・市場概要
・メーカー情報:Abbott Ltd、Jerome Stevens、Merck Serono、Alara Pharm (Sandoz)、KING PHARMS R AND D、Forest (Actavis)、Mylan、Piramal Healthcare
・メーカー別販売量、売上、市場シェア
・レボチロキシンの地域別市場分析
・レボチロキシンの北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・レボチロキシンのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・レボチロキシンのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・レボチロキシンの南米市場規模2015-2020:ブラジル、アルゼンチンなど
・レボチロキシンの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・レボチロキシンの種類別市場規模2015-2020:固体スライス、注射用ボトル
・レボチロキシンの用途別市場規模2015-2020:病院、化学者店、その他医療機関
・レボチロキシンの世界市場予測2021-2025:地域別、種類別、用途別
・販売チャンネル・代理店分析
・調査の結果・結論
【レポートの概要】

Market Overview
The Levothyroxine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Levothyroxine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Levothyroxine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Levothyroxine market has been segmented into
Slice in solid
In bottles for injection

By Application, Levothyroxine has been segmented into:
Hospitals
Chemist’s shops
Other medical institutions

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Levothyroxine market presented in the report. This section sheds light on the sales growth of different regional and country-level Levothyroxine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Levothyroxine market.

The report offers in-depth assessment of the growth and other aspects of the Levothyroxine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Levothyroxine Market Share Analysis
Levothyroxine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Levothyroxine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Levothyroxine sales, revenue and market share for each player covered in this report.

The major players covered in Levothyroxine are:
Abbott Ltd
Jerome Stevens
Merck Serono
Alara Pharm (Sandoz)
KING PHARMS R AND D
Forest (Actavis)
Mylan
Piramal Healthcare

Among other players domestic and global, Levothyroxine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Levothyroxine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Levothyroxine, with price, sales, revenue and global market share of Levothyroxine in 2018 and 2019.
Chapter 3, the Levothyroxine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Levothyroxine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Levothyroxine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Levothyroxine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Levothyroxine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Levothyroxine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Slice in solid
1.2.3 In bottles for injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Levothyroxine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Chemist’s shops
1.3.4 Other medical institutions
1.4 Overview of Global Levothyroxine Market
1.4.1 Global Levothyroxine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Ltd
2.1.1 Abbott Ltd Details
2.1.2 Abbott Ltd Major Business
2.1.3 Abbott Ltd SWOT Analysis
2.1.4 Abbott Ltd Product and Services
2.1.5 Abbott Ltd Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Jerome Stevens
2.2.1 Jerome Stevens Details
2.2.2 Jerome Stevens Major Business
2.2.3 Jerome Stevens SWOT Analysis
2.2.4 Jerome Stevens Product and Services
2.2.5 Jerome Stevens Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck Serono
2.3.1 Merck Serono Details
2.3.2 Merck Serono Major Business
2.3.3 Merck Serono SWOT Analysis
2.3.4 Merck Serono Product and Services
2.3.5 Merck Serono Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Alara Pharm (Sandoz)
2.4.1 Alara Pharm (Sandoz) Details
2.4.2 Alara Pharm (Sandoz) Major Business
2.4.3 Alara Pharm (Sandoz) SWOT Analysis
2.4.4 Alara Pharm (Sandoz) Product and Services
2.4.5 Alara Pharm (Sandoz) Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 KING PHARMS R AND D
2.5.1 KING PHARMS R AND D Details
2.5.2 KING PHARMS R AND D Major Business
2.5.3 KING PHARMS R AND D SWOT Analysis
2.5.4 KING PHARMS R AND D Product and Services
2.5.5 KING PHARMS R AND D Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Forest (Actavis)
2.6.1 Forest (Actavis) Details
2.6.2 Forest (Actavis) Major Business
2.6.3 Forest (Actavis) Product and Services
2.6.4 Forest (Actavis) Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Product and Services
2.7.4 Mylan Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Piramal Healthcare
2.8.1 Piramal Healthcare Details
2.8.2 Piramal Healthcare Major Business
2.8.3 Piramal Healthcare Product and Services
2.8.4 Piramal Healthcare Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Levothyroxine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Levothyroxine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Levothyroxine Manufacturer Market Share in 2019
3.3.2 Top 6 Levothyroxine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Levothyroxine Sales, Revenue and Market Share by Regions
4.1.1 Global Levothyroxine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Levothyroxine Revenue and Market Share by Regions (2015-2020)
4.2 North America Levothyroxine Sales and Growth Rate (2015-2020)
4.3 Europe Levothyroxine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Levothyroxine Sales and Growth Rate (2015-2020)
4.5 South America Levothyroxine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Levothyroxine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Levothyroxine Sales, Revenue and Market Share by Country
5.1.1 North America Levothyroxine Sales and Market Share by Country (2015-2020)
5.1.2 North America Levothyroxine Revenue and Market Share by Country (2015-2020)
5.2 United States Levothyroxine Sales and Growth Rate (2015-2020)
5.3 Canada Levothyroxine Sales and Growth Rate (2015-2020)
5.4 Mexico Levothyroxine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Levothyroxine Sales, Revenue and Market Share by Country
6.1.1 Europe Levothyroxine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Levothyroxine Revenue and Market Share by Country (2015-2020)
6.2 Germany Levothyroxine Sales and Growth Rate (2015-2020)
6.3 UK Levothyroxine Sales and Growth Rate (2015-2020)
6.4 France Levothyroxine Sales and Growth Rate (2015-2020)
6.5 Russia Levothyroxine Sales and Growth Rate (2015-2020)
6.6 Italy Levothyroxine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Levothyroxine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Levothyroxine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Levothyroxine Revenue and Market Share by Regions (2015-2020)
7.2 China Levothyroxine Sales and Growth Rate (2015-2020)
7.3 Japan Levothyroxine Sales and Growth Rate (2015-2020)
7.4 Korea Levothyroxine Sales and Growth Rate (2015-2020)
7.5 India Levothyroxine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Levothyroxine Sales and Growth Rate (2015-2020)
7.7 Australia Levothyroxine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Levothyroxine Sales, Revenue and Market Share by Country
8.1.1 South America Levothyroxine Sales and Market Share by Country (2015-2020)
8.1.2 South America Levothyroxine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Levothyroxine Sales and Growth Rate (2015-2020)
8.3 Argentina Levothyroxine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Levothyroxine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Levothyroxine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Levothyroxine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Levothyroxine Sales and Growth Rate (2015-2020)
9.3 Turkey Levothyroxine Sales and Growth Rate (2015-2020)
9.4 Egypt Levothyroxine Sales and Growth Rate (2015-2020)
9.5 South Africa Levothyroxine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Levothyroxine Sales and Market Share by Type (2015-2020)
10.2 Global Levothyroxine Revenue and Market Share by Type (2015-2020)
10.3 Global Levothyroxine Price by Type (2015-2020)
11 Global Levothyroxine Market Segment by Application
11.1 Global Levothyroxine Sales Market Share by Application (2015-2020)
11.2 Global Levothyroxine Revenue Market Share by Application (2015-2020)
11.3 Global Levothyroxine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Levothyroxine Sales, Revenue and Growth Rate (2021-2025)
12.2 Levothyroxine Market Forecast by Regions (2021-2025)
12.2.1 North America Levothyroxine Market Forecast (2021-2025)
12.2.2 Europe Levothyroxine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Levothyroxine Market Forecast (2021-2025)
12.2.4 South America Levothyroxine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Levothyroxine Market Forecast (2021-2025)
12.3 Levothyroxine Market Forecast by Type (2021-2025)
12.3.1 Global Levothyroxine Sales Forecast by Type (2021-2025)
12.3.2 Global Levothyroxine Market Share Forecast by Type (2021-2025)
12.4 Levothyroxine Market Forecast by Application (2021-2025)
12.4.1 Global Levothyroxine Sales Forecast by Application (2021-2025)
12.4.2 Global Levothyroxine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Levothyroxine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Levothyroxine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Levothyroxine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Levothyroxine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Abbott Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Abbott Ltd Levothyroxine Major Business
Table 10. Abbott Ltd Levothyroxine Total Revenue (USD Million) (2018-2019)
Table 11. Abbott Ltd SWOT Analysis
Table 12. Abbott Ltd Levothyroxine Product and Services
Table 13. Abbott Ltd Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Jerome Stevens Basic Information, Manufacturing Base and Competitors
Table 15. Jerome Stevens Levothyroxine Major Business
Table 16. Jerome Stevens Levothyroxine Total Revenue (USD Million) (2018-2019)
Table 17. Jerome Stevens SWOT Analysis
Table 18. Jerome Stevens Levothyroxine Product and Services
Table 19. Jerome Stevens Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Merck Serono Basic Information, Manufacturing Base and Competitors
Table 21. Merck Serono Levothyroxine Major Business
Table 22. Merck Serono Levothyroxine Total Revenue (USD Million) (2018-2019)
Table 23. Merck Serono SWOT Analysis
Table 24. Merck Serono Levothyroxine Product and Services
Table 25. Merck Serono Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Alara Pharm (Sandoz) Basic Information, Manufacturing Base and Competitors
Table 27. Alara Pharm (Sandoz) Levothyroxine Major Business
Table 28. Alara Pharm (Sandoz) Levothyroxine Total Revenue (USD Million) (2018-2019)
Table 29. Alara Pharm (Sandoz) SWOT Analysis
Table 30. Alara Pharm (Sandoz) Levothyroxine Product and Services
Table 31. Alara Pharm (Sandoz) Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. KING PHARMS R AND D Basic Information, Manufacturing Base and Competitors
Table 33. KING PHARMS R AND D Levothyroxine Major Business
Table 34. KING PHARMS R AND D Levothyroxine Total Revenue (USD Million) (2018-2019)
Table 35. KING PHARMS R AND D SWOT Analysis
Table 36. KING PHARMS R AND D Levothyroxine Product and Services
Table 37. KING PHARMS R AND D Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Forest (Actavis) Basic Information, Manufacturing Base and Competitors
Table 39. Forest (Actavis) Levothyroxine Major Business
Table 40. Forest (Actavis) Levothyroxine Total Revenue (USD Million) (2018-2019)
Table 41. Forest (Actavis) SWOT Analysis
Table 42. Forest (Actavis) Levothyroxine Product and Services
Table 43. Forest (Actavis) Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Mylan Basic Information, Manufacturing Base and Competitors
Table 45. Mylan Levothyroxine Major Business
Table 46. Mylan Levothyroxine Total Revenue (USD Million) (2018-2019)
Table 47. Mylan SWOT Analysis
Table 48. Mylan Levothyroxine Product and Services
Table 49. Mylan Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Piramal Healthcare Basic Information, Manufacturing Base and Competitors
Table 51. Piramal Healthcare Levothyroxine Major Business
Table 52. Piramal Healthcare Levothyroxine Total Revenue (USD Million) (2018-2019)
Table 53. Piramal Healthcare SWOT Analysis
Table 54. Piramal Healthcare Levothyroxine Product and Services
Table 55. Piramal Healthcare Levothyroxine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Global Levothyroxine Sales by Manufacturer (2018-2019) (K MT)
Table 57. Global Levothyroxine Revenue by Manufacturer (2018-2019) (USD Million)
Table 58. Global Levothyroxine Sales by Regions (2015-2020) (K MT)
Table 59. Global Levothyroxine Sales Market Share by Regions (2015-2020)
Table 60. Global Levothyroxine Revenue by Regions (2015-2020) (USD Million)
Table 61. North America Levothyroxine Sales by Countries (2015-2020) (K MT)
Table 62. North America Levothyroxine Sales Market Share by Countries (2015-2020)
Table 63. North America Levothyroxine Revenue by Countries (2015-2020) (USD Million)
Table 64. North America Levothyroxine Revenue Market Share by Countries (2015-2020)
Table 65. Europe Levothyroxine Sales by Countries (2015-2020) (K MT)
Table 66. Europe Levothyroxine Sales Market Share by Countries (2015-2020)
Table 67. Europe Levothyroxine Revenue by Countries (2015-2020) (USD Million)
Table 68. Asia-Pacific Levothyroxine Sales by Regions (2015-2020) (K MT)
Table 69. Asia-Pacific Levothyroxine Sales Market Share by Regions (2015-2020)
Table 70. Asia-Pacific Levothyroxine Revenue by Regions (2015-2020) (USD Million)
Table 71. South America Levothyroxine Sales by Countries (2015-2020) (K MT)
Table 72. South America Levothyroxine Sales Market Share by Countries (2015-2020)
Table 73. South America Levothyroxine Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Levothyroxine Revenue Market Share by Countries (2015-2020)
Table 75. Middle East & Africa Levothyroxine Sales by Countries (2015-2020) (K MT)
Table 76. Middle East & Africa Levothyroxine Sales Market Share by Countries (2015-2020)
Table 77. Middle East & Africa Levothyroxine Revenue by Countries (2015-2020) (USD Million)
Table 78. Middle East & Africa Levothyroxine Revenue Market Share by Countries (2015-2020)
Table 79. Global Levothyroxine Sales by Type (2015-2020) (K MT)
Table 80. Global Levothyroxine Sales Share by Type (2015-2020)
Table 81. Global Levothyroxine Revenue by Type (2015-2020) (USD Million)
Table 82. Global Levothyroxine Revenue Share by Type (2015-2020)
Table 83. Global Levothyroxine Sales by Application (2015-2020) (K MT)
Table 84. Global Levothyroxine Sales Share by Application (2015-2020)
Table 85. Global Levothyroxine Sales Forecast by Regions (2021-2025) (K MT)
Table 86. Global Levothyroxine Market Share Forecast by Regions (2021-2025)
Table 87. Global Levothyroxine Sales Forecast by Type (2021-2025) (K MT)
Table 88. Global Levothyroxine Market Share Forecast by Type (2021-2025)
Table 89. Global Levothyroxine Sales Forecast by Application (2021-2025)
Table 90. Global Levothyroxine Market Share Forecast by Application (2021-2025)
Table 91. Direct Channel Pros & Cons
Table 92. Indirect Channel Pros & Cons
Table 93. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Levothyroxine Picture
Figure 2. Global Sales Market Share of Levothyroxine by Type in 2019
Figure 3. Slice in solid Picture
Figure 4. In bottles for injection Picture
Figure 5. Levothyroxine Sales Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Chemist's shops Picture
Figure 8. Other medical institutions Picture
Figure 9. Global Levothyroxine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Levothyroxine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Levothyroxine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Levothyroxine Sales Market Share by Manufacturer in 2019
Figure 30. Global Levothyroxine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Levothyroxine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Levothyroxine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 35. Global Levothyroxine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Levothyroxine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Levothyroxine Revenue Market Share by Regions in 2018
Figure 38. North America Levothyroxine Sales and Growth Rate (2015-2020)
Figure 39. Europe Levothyroxine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Levothyroxine Sales and Growth Rate (2015-2020)
Figure 41. South America Levothyroxine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Levothyroxine Sales and Growth Rate (2015-2020)
Figure 43. North America Levothyroxine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Levothyroxine Sales Market Share by Countries (2015-2020)
Figure 45. North America Levothyroxine Sales Market Share by Countries in 2018
Figure 46. North America Levothyroxine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Levothyroxine Revenue Market Share by Countries in 2018
Figure 48. United States Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Canada Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Mexico Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Europe Levothyroxine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Levothyroxine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Levothyroxine Revenue Market Share by Countries in 2019
Figure 54. Germany Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 55. UK Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 56. France Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Russia Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Italy Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Asia-Pacific Levothyroxine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Levothyroxine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Levothyroxine Revenue Market Share by Regions 2019
Figure 62. China Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Japan Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Korea Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 65. India Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Southeast Asia Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 67. South America Levothyroxine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Levothyroxine Sales Market Share by Countries in 2019
Figure 69. South America Levothyroxine Revenue Market Share by Countries in 2019
Figure 70. Brazil Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Argentina Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Middle East and Africa Levothyroxine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Levothyroxine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Levothyroxine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Levothyroxine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Egypt Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Turkey Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 79. South Africa Levothyroxine Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Global Levothyroxine Sales and Growth Rate (2021-2025) (K MT)
Figure 81. Global Levothyroxine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Levothyroxine Market Forecast (2021-2025) (K MT)
Figure 83. Europe Sales Levothyroxine Market Forecast (2021-2025) (K MT)
Figure 84. Asia-Pacific Sales Levothyroxine Market Forecast (2021-2025) (K MT)
Figure 85. South America Sales Levothyroxine Market Forecast (2021-2025) (K MT)
Figure 86. Middle East & Africa Sales Levothyroxine Market Forecast (2021-2025) (K MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Abbott Ltd、Jerome Stevens、Merck Serono、Alara Pharm (Sandoz)、KING PHARMS R AND D、Forest (Actavis)、Mylan、Piramal Healthcare

★調査レポート[レボチロキシンの世界市場2020:メーカー別、地域別、種類・用途別] (コード:GIR20OC15418)販売に関する免責事項を必ずご確認ください。
★調査レポート[レボチロキシンの世界市場2020:メーカー別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆